ICT Media

ICT procurement trends in Pharmaceuticals - Enterprise ICT investment plans

  • KAB110105
  • 25 Pages
  • December 2013
  • ICT Media
Synopsis
This report presents the findings from a survey of 102 pharmaceutical companies regarding their approach to Information & Communications Technology (ICT) procurement. The survey investigates the way that pharmaceutical companies like to purchase technology, as well as the major IT and business objectives influencing their IT investment strategies.
Scope
Provides insights into pharmaceutical companies preferred buying approaches.

Comprehend the business objectives that pharmaceutical companies are looking to achieve through their IT investment strategy.

Appreciate the IT objectives that pharmaceutical companies are looking to achieve through their IT investment strategy.

Understand the factors that are influencing pharmaceutical companies decision to select an ICT provider.

Understand which organizational roles influence ICT purchasing decisions and signing off budgets.
Summary
Why was the report written?
To highlight the criteria on which pharmaceutical companies select their ICT providers as well as the roles which have influence while making ICT purchasing decisions.

What is the current market landscape and what is changing?
Most pharmaceutical companies are keen to deploy their technologies on-site as they have to adhere to strict compliance regulations relating to data security, however the demand for hosted services is also gaining traction.

What are the key drivers behind recent market changes?
Hosting is more popular in relation to technologies such as mobility and green IT & virtualization, with the aim of achieving cost and operational efficiencies.

What makes this report unique and essential to read?
Kable Global ICT Intelligence has invested significant resources in order to interview CIOs and IT managers about their IT Procurement. Very few IT analyst houses will have interviewed 100+ ICT decision makers in the pharmaceutical industry in H2 2012.
ReasonsToBuy
Pharmaceuticals companies have a higher preference for buying technologies from local resellers compared to national resellers, as they tend to be in a better position to provide timely support services and also possess vertical expertise.

The survey results indicate that pharmaceutical companies ICT investments are focused on increasing operational efficiencies by streamlining core business processes.

The objective of cutting costs has been assigned a moderate rating of X, as pharmaceutical companies look to reduce their overheads and operational costs.

Pharmaceutical companies dealing with constrained ICT budgets are looking to deploy technology solutions that offer value for money; therefore, ICT vendors who can offer flexible pricing models will have a competitive edge over their counterparts

According to Kables survey, 50% of Pharmaceutical companies state that they have an ICT infrastructure which is somewhat complex, with several hardware manufacturers, operating systems, databases, applications, and other elements, whilst 15% describe their ICT infrastructure as very complex with multiple instances of different technology types.
Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Telematics Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

Telematics by the synonym itself defines the integration of telecommunications and information and communications technologies abruptly called as informatics. It can be simply the technology of transmitting, receiving, sending and ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Circulating Tumor Cells Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

Circulating tumor cells (CTCs) are cells which detach from its primary or secondary tumors, enters in to the bloodstream and travel to distant organs. This is the evolving field of ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Glycobiology Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

The term glycobiology, also called as glycans, is the study of structure, function and biology of carbohydrate. They are the most essential components in living things. Merton Bernfield and colleagues ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Drug Testing Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

Drug testing includes different testing methods which are conducted to detect presence of drugs in the human body. These drugs are tested through blood, sweat, saliva, oral fluid and urine. ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Tissue Engineering and Regeneration Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Tissue engineering is developed from the field of biomaterials development and refers to the practice of combining cells or tissues with biologically active molecules into functional tissues. They are mainly ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Biopsy Devises Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

A biopsy is a medical test, mainly used to detect cancer, performed by surgeons, cardiologist or by radiologist. It involves in the extraction of sample cells or tissues for examination ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

2017 © Copyright Big Market Research

View Pricing >>